BAD HOMBURG, Germany--(BUSINESS WIRE)--July 25, 2005--Fresenius Medical Care AG (“the Company”) (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, is pleased to announce that Gary Brukardt, Renal Care Group’s President and Chief Executive Officer, will join Fresenius Medical Care and will be appointed as a Member of the Management Board of Fresenius Medical Care AG upon closing of the Renal Care Group acquisition. He will also become Vice Chairman of the Board of Directors of Fresenius Medical Care North America (FMCNA) and will serve on the Integration Steering Committee which oversees the integration of Renal Care Group’s operations into FMCNA. Gary Brukardt will be responsible for strategic planning, FMCNA’s perfusion business, physician practice management, chronic kidney disease management for FMCNA and disease state management including vascular access. As an FMC AG Management Board Member Gary Brukardt will share responsibility for FMCNA with Mats Wahlstrom and Rice Powell.
